{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:04:18Z","timestamp":1792605858039,"version":"4.5.0"},"reference-count":78,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Sciencs Foundation of China","doi-asserted-by":"publisher","award":["2022J011486"],"award-info":[{"award-number":["2022J011486"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Lung cancer remains a major global health threat due to its complex microenvironment,\nparticularly the role of neutrophils, which are crucial for tumor development and\nimmune evasion mechanisms. This study aimed to delve into the impact of lung cancer cell-conditioned\nmedia on neutrophil functions and their potential implications for lung cancer progression.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Employing in vitro experimental models, this study has analyzed the effects of lung cancer\ncell-conditioned media on neutrophil IL-8 and IFN-\u03b3 secretion, apoptosis, PD-L1 expression,\nand T-cell proliferation by using techniques, such as ELISA, flow cytometry, immunofluorescence,\nand CFSE proliferation assay. The roles of IL-8\/PD-L1 in regulating neutrophil functions were further\nexplored using inhibitors for IL-8 and PD-L1.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Lung cancer cell lines were found to secrete higher levels of IL-8 compared to normal\nlung epithelial cells. The conditioned media from lung cancer cells significantly reduced apoptosis\nin neutrophils, increased PD-L1 expression, and suppressed T-cell proliferation and IFN-\u03b3 secretion.\nThese effects were partially reversed in the presence of IL-8 inhibitors in Tumor Tissue Culture\nSupernatants (TTCS), while being further enhanced by IL-8. Both apoptosis and PD-L1 expression\nin neutrophils demonstrated dose-dependency to TTCS. Additionally, CFSE proliferation assay\nresults further confirmed the inhibitory effect of lung cancer cell-conditioned media on T-cell\nproliferation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study has revealed lung cancer cell-conditioned media to modulate neutrophil\nfunctions through regulating factors, such as IL-8, thereby affecting immune regulation and tumor\nprogression in the lung cancer microenvironment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115680096337237240909101904","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T06:27:57Z","timestamp":1727850477000},"page":"294-305","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor-Activated Neutrophils Promote Lung Cancer Progression through the IL-8\/PD-L1 Pathway"],"prefix":"10.2174","volume":"25","author":[{"given":"Yiping","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Nanping First Hospital Affiliated to Fujian Medical University,\nNanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Nanping First Hospital Affiliated to Fujian Medical University,\nNanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Nanping First Hospital Affiliated to Fujian Medical University,\nNanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanmei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Nanping First Hospital Affiliated to Fujian Medical University,\nNanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Nanping First Hospital Affiliated to Fujian Medical University,\nNanping, Fujian, 353006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/07357907.2022.2119479","volume":"41","author":"Abu Rous F.","year":"2023","unstructured":"Abu Rous F.; Singhi E.K.; Sridhar A.; Faisal M.S.; Desai A.; Lung cancer treatment advances in 2022. Cancer Invest  2023,41(1),12-24","journal-title":"Cancer Invest"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"115891","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Li Y.","year":"2023","unstructured":"Li Y.; Yan B.; He S.; Advances and challenges in the treatment of lung cancer. Biomed Pharmacother  2023,169,115891","journal-title":"Biomed Pharmacother"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1055\/s-0042-1757885","volume":"43","author":"Lee E.","year":"2022","unstructured":"Lee E.; Kazerooni E.A.; Lung Cancer Screening. Semin Respir Crit Care Med  2022,43(6),839-850","journal-title":"Semin Respir Crit Care Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.3390\/ijms22168661","volume":"22","author":"Nooreldeen R.","year":"2021","unstructured":"Nooreldeen R.; Bach H.; Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci  2021,22(16),8661","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"Thai A.A.","year":"2021","unstructured":"Thai A.A.; Solomon B.J.; Sequist L.V.; Gainor J.F.; Heist R.S.; Lung cancer. Lancet  2021,398(10299),535-554","journal-title":"Lancet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.hoc.2023.02.011","volume":"37","author":"Yao J.","year":"2023","unstructured":"Yao J.; Novosel M.; Bellampalli S.; Kapo J.; Joseph J.; Prsic E.; Lung Cancer Supportive Care and Symptom Management. Hematol Oncol Clin North Am  2023,37(3),609-622","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.thorsurg.2022.04.005","volume":"32","author":"Jiwnani S.","year":"2022","unstructured":"Jiwnani S.; Penumadu P.; Ashok A.; Pramesh C.S.; Lung Cancer Management in Low and Middle-Income Countries. Thorac Surg Clin  2022,32(3),383-395","journal-title":"Thorac Surg Clin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.48095\/ccko2021S71","volume":"34","author":"Petru\u017eelka L.","year":"2021","unstructured":"Petru\u017eelka L.; \u0160pa\u010dek J.; K\u0159\u00ed\u017eov\u00e1 \u0139.; Future of lung cancer treatment. Klin Onkol  2021,34,71-81","journal-title":"Klin Onkol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.semdp.2021.05.001","volume":"38","author":"Jain D.","year":"2021","unstructured":"Jain D.; Roy-Chowdhuri S.; Advances in cytology of lung cancer. Semin Diagn Pathol  2021,38(5),109-115","journal-title":"Semin Diagn Pathol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/biom13060877","volume":"13","author":"Yang H.","year":"2023","unstructured":"Yang H.; Liu Y.; Chen L.; Zhao J.; Guo M.; Zhao X.; Wen Z.; He Z.; Chen C.; Xu L.; MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges? Biomolecules  2023,13(6),877","journal-title":"Biomolecules"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2023.05.008","volume":"93","author":"Lee J.","year":"2023","unstructured":"Lee J.; Saxena A.; Giaccone G.; Advancements in small cell lung cancer. Semin Cancer Biol  2023,93,123-128","journal-title":"Semin Cancer Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41571-020-00432-6","volume":"18","author":"Oudkerk M.","year":"2021","unstructured":"Oudkerk M.; Liu S.; Heuvelmans M.A.; Walter J.E.; Field J.K.; Lung cancer LDCT screening and mortality reduction \u2014 Evidence, pitfalls and future perspectives. Nat Rev Clin Oncol  2021,18(3),135-151","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"102315","DOI":"10.1016\/j.arr.2024.102315","volume":"97","author":"Jha S.K.","year":"2024","unstructured":"Jha S.K.; De Rubis G.; Devkota S.R.; Zhang Y.; Adhikari R.; Jha L.A.; Bhattacharya K.; Mehndiratta S.; Gupta G.; Singh S.K.; Panth N.; Dua K.; Hansbro P.M.; Paudel K.R.; Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions. Ageing Res Rev  2024,97,102315","journal-title":"Ageing Res Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13353-023-00750-2","volume":"64","author":"Frydrychowicz M.","year":"2023","unstructured":"Frydrychowicz M.; Kuszel \u0141.; Dworacki G.; Budna-Tukan J.; MicroRNA in lung cancer\u2014A novel potential way for early diagnosis and therapy. J Appl Genet  2023,64(3),459-477","journal-title":"J Appl Genet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","volume":"15","author":"Hu J.","year":"2023","unstructured":"Hu J.; Zhang L.; Xia H.; Yan Y.; Zhu X.; Sun F.; Sun L.; Li S.; Li D.; Wang J.; Han Y.; Zhang J.; Bian D.; Yu H.; Chen Y.; Fan P.; Ma Q.; Jiang G.; Wang C.; Zhang P.; Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Med  2023,15(1),14","journal-title":"Genome Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1097\/CM9.0000000000002127","volume":"135","author":"Liu W.","year":"2022","unstructured":"Liu W.; Powell C.A.; Wang Q.; Tumor microenvironment in lung cancer-derived brain metastasis. Chin Med J (Engl)  2022,135(15),1781-1791","journal-title":"Chin Med J (Engl)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"Cords L.","year":"2024","unstructured":"Cords L.; Engler S.; Haberecker M.; R\u00fcschoff J.H.; Moch H.; de Souza N.; Bodenmiller B.; Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell  2024,42(3),396-412.e5","journal-title":"Cancer Cell"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1038\/s41467-022-33968-5","volume":"13","author":"Cao B.","year":"2022","unstructured":"Cao B.; Liu M.; Wang L.; Zhu K.; Cai M.; Chen X.; Feng Y.; Yang S.; Fu S.; Zhi C.; Ye X.; Zhang J.; Zhang Z.; Yang X.; Zhao M.; Wu Q.; Xu L.; Yang L.; Lian H.; Zhao Q.; Zhang Z.; Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer. Nat Commun  2022,13(1),6203","journal-title":"Nat Commun"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.7150\/ijbs.70958","volume":"18","author":"Zhao Y.","year":"2022","unstructured":"Zhao Y.; Guo S.; Deng J.; Shen J.; Du F.; Wu X.; Chen Y.; Li M.; Chen M.; Li X.; Li W.; Gu L.; Sun Y.; Wen Q.; Li J.; Xiao Z.; VEGF\/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment. Int J Biol Sci  2022,18(9),3845-3858","journal-title":"Int J Biol Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"802080","DOI":"10.3389\/fimmu.2021.802080","volume":"12","author":"Zhang J.","year":"2022","unstructured":"Zhang J.; Song C.; Tian Y.; Yang X.; Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment. Front Immunol  2022,12,802080","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"829451","DOI":"10.3389\/fimmu.2022.829451","volume":"13","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Chen R.; Wa Y.; Ding S.; Yang Y.; Liao J.; Tong L.; Xiao G.; Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer. Front Immunol  2022,13,829451","journal-title":"Front Immunol"},{"key":"ref=22","first-page":"950","volume":"13","author":"Xue Q.","year":"2023","unstructured":"Xue Q.; Wang Y.; Zheng Q.; Chen L.; Lin Y.; Jin Y.; Shen X.; Li Y.; Prognostic value of tumor immune microenvironment factors in patients with stage I lung adenocarcinoma. Am J Cancer Res  2023,13(3),950-963","journal-title":"Am J Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"848476","DOI":"10.3389\/fgene.2022.848476","volume":"13","author":"Lin Y.","year":"2022","unstructured":"Lin Y.; Zhou H.; Li S.; BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma. Front Genet  2022,13,848476","journal-title":"Front Genet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3389\/fimmu.2018.03101","volume":"9","author":"Stankovic B.","year":"2019","unstructured":"Stankovic B.; Bj\u00f8rhovde H.A.K.; Skarshaug R.; Aamodt H.; Frafjord A.; M\u00fcller E.; Hammarstr\u00f6m C.; Beraki K.; B\u00e6kkevold E.S.; Woldb\u00e6k P.R.; Helland \u00c5.; Brustugun O.T.; \u00d8ynebr\u00e5ten I.; Corthay A.; Immune Cell Composition in Human Non-small Cell Lung Cancer. Front Immunol  2019,9,3101","journal-title":"Front Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcancer.2022.09.005","volume":"86","author":"Li T.","year":"2022","unstructured":"Li T.; Qiao T.; Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy. Semin Cancer Biol  2022,86(Pt 2),117-125","journal-title":"Semin Cancer Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-20-2870","volume":"81","author":"Ancey P.B.","year":"2021","unstructured":"Ancey P.B.; Contat C.; Boivin G.; Sabatino S.; Pascual J.; Zangger N.; Perentes J.Y.; Peters S.; Abel E.D.; Kirsch D.G.; Rathmell J.C.; Vozenin M.C.; Meylan E.; GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy. Cancer Res  2021,81(9),2345-2357","journal-title":"Cancer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2024.01.013","volume":"42","author":"He X.Y.","year":"2024","unstructured":"He X.Y.; Gao Y.; Ng D.; Michalopoulou E.; George S.; Adrover J.M.; Sun L.; Albrengues J.; Da\u00dfler-Plenker J.; Han X.; Wan L.; Wu X.S.; Shui L.S.; Huang Y.H.; Liu B.; Su C.; Spector D.L.; Vakoc C.R.; Van Aelst L.; Egeblad M.; Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell  2024,42(3),474-486.e12","journal-title":"Cancer Cell"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","volume":"13","author":"Zhang Q.","year":"2022","unstructured":"Zhang Q.; Abdo R.; Iosef C.; Kaneko T.; Cecchini M.; Han V.K.; Li S.S.C.; The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Nat Commun  2022,13(1),5983","journal-title":"Nat Commun"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1016817","DOI":"10.3389\/fimmu.2022.1016817","volume":"13","author":"Liu Y.","year":"2022","unstructured":"Liu Y.; Li C.; Lu Y.; Liu C.; Yang W.; Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front Immunol  2022,13,1016817","journal-title":"Front Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/EBC20220245","volume":"67","author":"Ramon-Gil E.","year":"2023","unstructured":"Ramon-Gil E.; Geh D.; Leslie J.; Harnessing neutrophil plasticity for HCC immunotherapy. Essays Biochem  2023,67(6),941-955","journal-title":"Essays Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e1340","DOI":"10.1002\/ctm2.1340","volume":"13","author":"Peng H.","year":"2023","unstructured":"Peng H.; Wu X.; Liu S.; He M.; Tang C.; Wen Y.; Xie C.; Zhong R.; Li C.; Xiong S.; Liu J.; Zheng H.; He J.; Lu X.; Liang W.; Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil. Clin Transl Med  2023,13(7),e1340","journal-title":"Clin Transl Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.apsb.2023.01.020","volume":"13","author":"Chan Y.","year":"2023","unstructured":"Chan Y.; Tan H.; Lu Y.; Zhang C.; Cheng C.; Wu J.; Wang N.; Feng Y.; Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharm Sin B  2023,13(4),1554-1567","journal-title":"Acta Pharm Sin B"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1093990","DOI":"10.3389\/fimmu.2022.1093990","volume":"13","author":"He L.","year":"2023","unstructured":"He L.; Kang Q.; Chan K.I.; Zhang Y.; Zhong Z.; Tan W.; The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front Immunol  2023,13,1093990","journal-title":"Front Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"688625","DOI":"10.3389\/fphar.2021.688625","volume":"12","author":"Tan Z.","year":"2021","unstructured":"Tan Z.; Xue H.; Sun Y.; Zhang C.; Song Y.; Qi Y.; The Role of Tumor Inflammatory Microenvironment in Lung Cancer. Front Pharmacol  2021,12,688625","journal-title":"Front Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"785222","DOI":"10.3389\/fimmu.2021.785222","volume":"12","author":"Kaltenmeier C.","year":"2021","unstructured":"Kaltenmeier C.; Yazdani H.O.; Morder K.; Geller D.A.; Simmons R.L.; Tohme S.; Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment. Front Immunol  2021,12,785222","journal-title":"Front Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3390\/jcm11071855","volume":"11","author":"Ushio R.","year":"2022","unstructured":"Ushio R.; Murakami S.; Saito H.; Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. J Clin Med  2022,11(7),1855","journal-title":"J Clin Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"103209","DOI":"10.1016\/j.redox.2024.103209","volume":"74","author":"Gu X.","year":"2024","unstructured":"Gu X.; Zhu Y.; Su J.; Wang S.; Su X.; Ding X.; Jiang L.; Fei X.; Zhang W.; Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. Redox Biol  2024,74,103209","journal-title":"Redox Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.2147\/IJGM.S353592","volume":"15","author":"Tao Q.","year":"2022","unstructured":"Tao Q.; Li X.; Zhu T.; Ge X.; Gong S.; Guo J.; Ma R.; Lactate Transporter SLC16A3 (MCT4) as an Onco-Immunological Biomarker Associating Tumor Microenvironment and Immune Responses in Lung Cancer. Int J Gen Med  2022,15,4465-4474","journal-title":"Int J Gen Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e000326","DOI":"10.1136\/jitc-2019-000326","volume":"8","author":"Horn L.A.","year":"2020","unstructured":"Horn L.A.; Riskin J.; Hempel H.A.; Fousek K.; Lind H.; Hamilton D.H.; McCampbell K.K.; Maeda D.Y.; Zebala J.A.; Su Z.; Schlom J.; Palena C.; Simultaneous inhibition of CXCR1\/2, TGF-\u03b2, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity. J Immunother Cancer  2020,8(1),e000326","journal-title":"J Immunother Cancer"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12929-022-00877-0","volume":"29","author":"Yuliani F.S.","year":"2022","unstructured":"Yuliani F.S.; Chen J.Y.; Cheng W.H.; Wen H.C.; Chen B.C.; Lin C.H.; Thrombin induces IL-8\/CXCL8 expression by DCLK1-dependent RhoA and YAP activation in human lung epithelial cells. J Biomed Sci  2022,29(1),95","journal-title":"J Biomed Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41590-022-01170-w","volume":"23","author":"Perry J.A.","year":"2022","unstructured":"Perry J.A.; Shallberg L.; Clark J.T.; Gullicksrud J.A.; DeLong J.H.; Douglas B.B.; Hart A.P.; Lanzar Z.; O\u2019Dea K.; Konradt C.; Park J.; Kuchroo J.R.; Grubaugh D.; Zaretsky A.G.; Brodsky I.E.; Malefyt R.W.; Christian D.A.; Sharpe A.H.; Hunter C.A.; PD-L1\u2013PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection. Nat Immunol  2022,23(5),743-756","journal-title":"Nat Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.immuni.2022.12.006","volume":"56","author":"Tichet M.","year":"2023","unstructured":"Tichet M.; Wullschleger S.; Chryplewicz A.; Fournier N.; Marcone R.; Kauzlaric A.; Homicsko K.; Deak L.C.; Uma\u00f1a P.; Klein C.; Hanahan D.; Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8 T cells and reprogramming macrophages. Immunity  2023,56(1),162-179.e6","journal-title":"Immunity"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Huang Q.","year":"2022","unstructured":"Huang Q.; Wu X.; Wang Z.; Chen X.; Wang L.; Lu Y.; Xiong D.; Liu Q.; Tian Y.; Lin H.; Guo J.; Wen S.; Dong W.; Yang X.; Yuan Y.; Yue Z.; Lei S.; Wu Q.; Ran L.; Xie L.; Wang Y.; Gao L.; Tian Q.; Zhou X.; Sun B.; Xu L.; Tang Z.; Ye L.; The primordial differentiation of tumor-specific memory CD8 T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell  2022,185(22),4049-4066.e25","journal-title":"Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.CIR-21-0515","volume":"10","author":"Budimir N.","year":"2022","unstructured":"Budimir N.; Thomas G.D.; Dolina J.S.; Salek-Ardakani S.; Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1\/PD-L1 Immune Checkpoint Blockade. Cancer Immunol Res  2022,10(2),146-153","journal-title":"Cancer Immunol Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41417-022-00551-5","volume":"30","author":"Song S.","year":"2023","unstructured":"Song S.; Zhang Y.; Duan X.; Liu C.; Du Y.; Wang X.; Luo Y.; Cui Y.; HIF-1\u03b1\/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression. Cancer Gene Ther  2023,30(2),358-367","journal-title":"Cancer Gene Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jnci\/djab183","volume":"114","author":"Tanaka I.","year":"2022","unstructured":"Tanaka I.; Dayde D.; Tai M.C.; Mori H.; Solis L.M.; Tripathi S.C.; Fahrmann J.F.; Unver N.; Parhy G.; Jain R.; Parra E.R.; Murakami Y.; Aguilar-Bonavides C.; Mino B.; Celiktas M.; Dhillon D.; Casabar J.P.; Nakatochi M.; Stingo F.; Baladandayuthapani V.; Wang H.; Katayama H.; Dennison J.B.; Lorenzi P.L.; Do K.A.; Fujimoto J.; Behrens C.; Ostrin E.J.; Rodriguez-Canales J.; Hase T.; Fukui T.; Kajino T.; Kato S.; Yatabe Y.; Hosoda W.; Kawaguchi K.; Yokoi K.; Chen-Yoshikawa T.F.; Hasegawa Y.; Gazdar A.F.; Wistuba I.I.; Hanash S.; Taguchi A.; SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1\u2013Negative Lung Adenocarcinomas. J Natl Cancer Inst  2022,114(2),290-301","journal-title":"J Natl Cancer Inst"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13048-023-01207-0","volume":"16","author":"Wu Y.","year":"2023","unstructured":"Wu Y.; Liu Q.; Xie Y.; Zhu J.; Zhang S.; Ge Y.; Guo J.; Luo N.; Huang W.; Xu R.; Liu S.; Cheng Z.; MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer. J Ovarian Res  2023,16(1),181","journal-title":"J Ovarian Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"672499","DOI":"10.3389\/fendo.2021.672499","volume":"12","author":"Giannetta E.","year":"2021","unstructured":"Giannetta E.; La Salvia A.; Rizza L.; Muscogiuri G.; Campione S.; Pozza C.; Colao A.A.L.I.; Faggiano A.; Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms? Front Endocrinol (Lausanne)  2021,12,672499","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41419-022-05495-0","volume":"13","author":"Favaro F.","year":"2022","unstructured":"Favaro F.; Luciano-Mateo F.; Moreno-Caceres J.; Hern\u00e1ndez-Madrigal M.; Both D.; Montironi C.; P\u00fcschel F.; Nadal E.; Eldering E.; Mu\u00f1oz-Pinedo C.; TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinoma. Cell Death Dis  2022,13(12),1046","journal-title":"Cell Death Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s42003-021-01769-z","volume":"4","author":"Li X.","year":"2021","unstructured":"Li X.; Chen J.; Chen Y.J.; Qiao Y.D.; Zhao L.Y.; Jiang N.; Wu X.Y.; Xing Y.F.; Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion. Commun Biol  2021,4(1),252","journal-title":"Commun Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/JS9.0000000000000943","volume":"110","author":"Liu Y.","year":"2024","unstructured":"Liu Y.; Li Z.; Meng Q.; Ning A.; Zhou S.; Li S.; Tao X.; Wu Y.; Chen Q.; Tian T.; Zhang L.; Cui J.; Mao L.; Chu M.; Identification of the consistently differential expressed hub mRNAs and proteins in lung adenocarcinoma and construction of the prognostic signature: A multidimensional analysis. Int J Surg  2024,110(2),1052-1067","journal-title":"Int J Surg"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12944-022-01755-2","volume":"21","author":"Xiong H.","year":"2022","unstructured":"Xiong H.; Ye J.; Xie K.; Hu W.; Xu N.; Yang H.; Exosomal IL-8 derived from Lung Cancer and Colon Cancer cells induced adipocyte atrophy via NF-\u03baB signaling pathway. Lipids Health Dis  2022,21(1),147","journal-title":"Lipids Health Dis"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jleuko\/qiad004","volume":"113","author":"Sheng Y.","year":"2023","unstructured":"Sheng Y.; Peng W.; Huang Y.; Cheng L.; Meng Y.; Kwantwi L.B.; Yang J.; Xu J.; Xiao H.; Kzhyshkowska J.; Wu Q.; Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis. J Leukoc Biol  2023,113(4),383-399","journal-title":"J Leukoc Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"bqad061","DOI":"10.1210\/endocr\/bqad061","volume":"164","author":"Minor B.M.N.","year":"2023","unstructured":"Minor B.M.N.; LeMoine D.; Seger C.; Gibbons E.; Koudouovoh J.; Taya M.; Kurtz D.; Xu Y.; Hammes S.R.; Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models. Endocrinology  2023,164(6),bqad061","journal-title":"Endocrinology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"Tsilimigras D.I.","year":"2021","unstructured":"Tsilimigras D.I.; Brodt P.; Clavien P.A.; Muschel R.J.; D\u2019Angelica M.I.; Endo I.; Parks R.W.; Doyle M.; de Santiba\u00f1es E.; Pawlik T.M.; Liver metastases. Nat Rev Dis Primers  2021,7(1),27","journal-title":"Nat Rev Dis Primers"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","volume":"621","author":"Wang C.","year":"2023","unstructured":"Wang C.; Zheng X.; Zhang J.; Jiang X.; Wang J.; Li Y.; Li X.; Shen G.; Peng J.; Zheng P.; Gu Y.; Chen J.; Lin M.; Deng C.; Gao H.; Lu Z.; Zhao Y.; Luo M.; CD300ld on neutrophils is required for tumour-driven immune suppression. Nature  2023,621(7980),830-839","journal-title":"Nature"},{"key":"ref=57","first-page":"2023","volume":"119493","author":"Zhong J.","year":"1870","unstructured":"Zhong J.; Zong S.; Wang J.; Feng M.; Wang J.; Zhang H.; Xiong L.; Role of neutrophils on cancer cells and other immune cells in the tumor microenvironment. Biochim Biophys Acta Mol Cell Res  1870,119493,2023","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=58","first-page":"251","volume":"43","author":"Hiramatsu S.","year":"2020","unstructured":"Hiramatsu S.; Tanaka H.; Nishimura J.; Yamakoshi Y.; Sakimura C.; Tamura T.; Toyokawa T.; Muguruma K.; Yashiro M.; Hirakawa K.; Ohira M.; Gastric cancer cells alter the immunosuppressive function of neutrophils. Oncol Rep  2020,43(1),251-259","journal-title":"Oncol Rep"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/2326-6066.CIR-22-0939","volume":"11","author":"Roetman J.J.","year":"2023","unstructured":"Roetman J.J.; Erwin M.M.; Rudloff M.W.; Favret N.R.; Detr\u00e9s Rom\u00e1n C.R.; Apostolova M.K.I.; Murray K.A.; Lee T.F.; Lee Y.A.; Philip M.; Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1\u2212 Dysfunctional State. Cancer Immunol Res  2023,11(12),1630-1641","journal-title":"Cancer Immunol Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2300110","DOI":"10.1002\/advs.202300110","volume":"10","author":"Li H.","year":"2023","unstructured":"Li H.; Chen J.; Li Z.; Chen M.; Ou Z.; Mo M.; Wang R.; Tong S.; Liu P.; Cai Z.; Zhang C.; Liu Z.; Deng D.; Liu J.; Cheng C.; Hu J.; Zu X.; S100A5 Attenuates Efficiency of Anti-PD-L1\/PD-1 Immunotherapy by Inhibiting CD8  T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma. Adv Sci (Weinh)  2023,10(25),2300110","journal-title":"Adv Sci (Weinh)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2207155","DOI":"10.1002\/advs.202207155","volume":"10","author":"Cai Z.","year":"2023","unstructured":"Cai Z.; Chen J.; Yu Z.; Li H.; Liu Z.; Deng D.; Liu J.; Chen C.; Zhang C.; Ou Z.; Chen M.; Hu J.; Zu X.; BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1\/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity. Adv Sci (Weinh)  2023,10(8),2207155","journal-title":"Adv Sci (Weinh)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"109051","DOI":"10.1016\/j.intimp.2022.109051","volume":"110","author":"Liang Y.","year":"2022","unstructured":"Liang Y.; Shen J.; Lan Q.; Zhang K.; Xu Y.; Duah M.; Xu K.; Pan B.; Blockade of PD-1\/PD-L1 increases effector T cells and aggravates murine chronic graft-versus-host disease. Int Immunopharmacol  2022,110,109051","journal-title":"Int Immunopharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e13129","DOI":"10.1111\/sji.13129","volume":"95","author":"Zhulai G.","year":"2022","unstructured":"Zhulai G.; Oleinik E.; Targeting regulatory T cells in anti\u2010PD\u20101\/PD\u2010L1 cancer immunotherapy. Scand J Immunol  2022,95(3),e13129","journal-title":"Scand J Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/vaccines11020313","volume":"11","author":"Gulden G.","year":"2023","unstructured":"Gulden G.; Sert B.; Teymur T.; Ay Y.; Tiryaki N.N.; Mishra A.K.; Ovali E.; Tarhan N.; Tastan C.; CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. Vaccines (Basel)  2023,11(2),313","journal-title":"Vaccines (Basel)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/abr.abr_349_21","volume":"11","author":"Rahimmanesh I.","year":"2022","unstructured":"Rahimmanesh I.; Tavangar M.; Zahedi S.N.; Azizi Y.; Khanahmad Shahreza H.; Optimization of Culture Media for Ex vivo T-Cell Expansion for Adoptive T-Cell Therapy. Adv Biomed Res  2022,11(1),94","journal-title":"Adv Biomed Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"458","DOI":"10.18502\/ijaai.v21i4.10293","volume":"21","author":"Kashef S.","year":"2022","unstructured":"Kashef S.; Moghtaderi M.; Hatami H.R.; Kalani M.; Alyasin S.; Nabavizadeh H.; Farjadian S.; Evaluation of T Cell Proliferation Using CFSE Dilution Assay: A Comparison between Stimulation with PHA and Anti-CD3\/Anti-CD28 Coated Beads. Iran J Allergy Asthma Immunol  2022,21(4),458-466","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"109014","DOI":"10.1016\/j.clim.2022.109014","volume":"238","author":"Habiballah S.B.","year":"2022","unstructured":"Habiballah S.B.; Whangbo J.S.; Cardona I.D.; Platt C.D.; Spontaneous resolution of severe idiopathic T cell lymphopenia. Clin Immunol  2022,238,109014","journal-title":"Clin Immunol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-023-02711-3","volume":"42","author":"Cui Y.","year":"2023","unstructured":"Cui Y.; Li J.; Zhang P.; Yin D.; Wang Z.; Dai J.; Wang W.; Zhang E.; Guo R.; B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. J Exp Clin Cancer Res  2023,42(1),146","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.3390\/ijms23126489","volume":"23","author":"Madeddu C.","year":"2022","unstructured":"Madeddu C.; Donisi C.; Liscia N.; Lai E.; Scartozzi M.; Macci\u00f2 A.; EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment. Int J Mol Sci  2022,23(12),6489","journal-title":"Int J Mol Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/cells10020343","volume":"10","author":"Vico-Barranco I.","year":"2021","unstructured":"Vico-Barranco I.; Arbulo-Echevarria M.M.; Serrano-Garc\u00eda I.; P\u00e9rez-Linaza A.; Miranda-Sayago J.M.; Miazek A.; Narbona-S\u00e1nchez I.; Aguado E.; A Novel, LAT\/Lck Double Deficient T Cell Subline J.CaM1.7 for Combined Analysis of Early TCR Signaling. Cells  2021,10(2),343","journal-title":"Cells"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1039\/D0TB02235G","volume":"9","author":"Ahmadi A.","year":"2021","unstructured":"Ahmadi A.; Ayyadevara V.S.S.A.; Baudry J.; Roh K.H.; Calcium signaling on Jurkat T cells induced by microbeads coated with novel peptide ligands specific to human CD3\u03b5. J Mater Chem B Mater Biol Med  2021,9(6),1661-1675","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.mcb.2022.09.012","volume":"178","author":"Carrasco-Padilla C.","year":"2023","unstructured":"Carrasco-Padilla C.; Aguilar-Sope\u00f1a O.; G\u00f3mez-Mor\u00f3n A.; Alegre-G\u00f3mez S.; S\u00e1nchez-Madrid F.; Mart\u00edn-C\u00f3freces N.B.; Roda-Navarro P.; T cell activation and effector function in the human Jurkat T cell model. Methods Cell Biol  2023,178,25-41","journal-title":"Methods Cell Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"12287","DOI":"10.1002\/jev2.12287","volume":"11","author":"Jung D.","year":"2022","unstructured":"Jung D.; Shin S.; Kang S.M.; Jung I.; Ryu S.; Noh S.; Choi S.J.; Jeong J.; Lee B.Y.; Kim K.S.; Kim C.S.; Yoon J.H.; Lee C.H.; Bucher F.; Kim Y.N.; Im S.H.; Song B.J.; Yea K.; Baek M.C.; Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery. J Extracell Vesicles  2022,11(12),12287","journal-title":"J Extracell Vesicles"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"112317","DOI":"10.1016\/j.celrep.2023.112317","volume":"42","author":"Geiger K.M.","year":"2023","unstructured":"Geiger K.M.; Manoharan M.; Coombs R.; Arana K.; Park C.S.; Lee A.Y.; Shastri N.; Robey E.A.; Coscoy L.; Murine cytomegalovirus downregulates ERAAP and induces an unconventional T cell response to self. Cell Rep  2023,42(4),112317","journal-title":"Cell Rep"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","volume":"56","author":"Zagorulya M.","year":"2023","unstructured":"Zagorulya M.; Yim L.; Morgan D.M.; Edwards A.; Torres-Mejia E.; Momin N.; McCreery C.V.; Zamora I.L.; Horton B.L.; Fox J.G.; Wittrup K.D.; Love J.C.; Spranger S.; Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer. Immunity  2023,56(2),386-405.e10","journal-title":"Immunity"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1111\/1759-7714.14606","volume":"13","author":"Cui Z.","year":"2022","unstructured":"Cui Z.; Ruan Z.; Zeng J.; Sun J.; Ye W.; Xu W.; Guo X.; Zhang L.; Song L.; Lung-specific exosomes for co-delivery of CD47 blockade and cisplatin for the treatment of non-small cell lung cancer. Thorac Cancer  2022,13(19),2723-2731","journal-title":"Thorac Cancer"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cac2.12244","volume":"42","author":"Cheng B.","year":"2022","unstructured":"Cheng B.; Ding K.; Chen P.; Ji J.; Luo T.; Guo X.; Qiu W.; Ma C.; Meng X.; Wang J.; Yu J.; Liu Y.; Anti-PD-L1\/TGF-\u03b2R fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1\/PD-L1 inhibitors in lung cancer. Cancer Commun (Lond)  2022,42(1),17-36","journal-title":"Cancer Commun (Lond)"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"e005769","DOI":"10.1136\/jitc-2022-005769","volume":"10","author":"Peng P.","year":"2022","unstructured":"Peng P.; Lou Y.; Wang S.; Wang J.; Zhang Z.; Du P.; Zheng J.; Liu P.; Xu L.X.; Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-\u03b3 to modulate antitumor T-cell response after cryo-thermal therapy. J Immunother Cancer  2022,10(12),e005769","journal-title":"J Immunother Cancer"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680096337237240909101904","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234695\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680096337237240909101904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T13:04:33Z","timestamp":1737378273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234695\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680096337237240909101904","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}